• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种用于研究PSMA - 11在水溶液中不稳定性的高效液相色谱和超高效液相色谱 - 高分辨质谱方法。

An HPLC and UHPLC-HRMS approach to study PSMA-11 instability in aqueous solution.

作者信息

Iudicello Antonella, Genovese Filippo, Di Iorio Valentina, Cicoria Gianfranco, Boschi Stefano

机构信息

Pharmaceutical Department, Azienda USL of Modena, Largo del Pozzo, 71, 41121, Modena, Italy.

Oncology and Hematology Department, Nuclear Medicine Unit, Azienda Ospedaliero-Universitaria of Modena, Largo del Pozzo, 71, 41121, Modena, Italy.

出版信息

EJNMMI Radiopharm Chem. 2021 Mar 24;6(1):14. doi: 10.1186/s41181-021-00122-3.

DOI:10.1186/s41181-021-00122-3
PMID:33761040
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7990985/
Abstract

BACKGROUND

The stability of precursors and reagents is of utmost importance for developing a robust radiolabelling method that provides high and constant radiochemical yield and radiochemical purity. While performing the QC of the [Ga]Ga-PSMA-11 injectable solutions according to Ph. Eur. Monograph that has recently been published, a trend to the instability of the standard PSMA-11, the same used as a precursor for [Ga]Ga-PSMA-11 radiosynthesis, has been observed. This instability led to the formation of a side product in a time-dependent manner. The formation of this compound, besides making the implementation of the Ph. Eur. analytical method more difficult, negatively influenced the radiochemical yield and the radiochemical purity by increasing gallium-68 in colloidal and ionic forms.

RESULTS

The nature of the side product was investigated by adding chelators, such as EDTA, to PSMA-11 solutions and using the combination of UHPLC-HRMS. The results led to the definition of the side product structure, as Fe-PSMA-11, from the combination of the high-affinity chelator HBED-CC, present in the molecule of PSMA-11, and environmental Fe (III).

CONCLUSIONS

Strategies to reduce the risk of low radiolabeling yields and to increase the stability of the PSMA-11 in an aqueous solution were also discussed.

摘要

背景

前体和试剂的稳定性对于开发一种稳健的放射性标记方法至关重要,该方法可提供高且恒定的放射化学产率和放射化学纯度。在根据最近发布的欧洲药典专论对[镓]镓 - PSMA - 11注射溶液进行质量控制时,观察到标准PSMA - 11(用作[镓]镓 - PSMA - 11放射性合成前体)存在不稳定趋势。这种不稳定性导致以时间依赖的方式形成一种副产物。该化合物的形成,除了使欧洲药典分析方法的实施更加困难外,还通过增加胶体和离子形式的镓 - 68对放射化学产率和放射化学纯度产生负面影响。

结果

通过向PSMA - 11溶液中添加螯合剂(如EDTA)并使用UHPLC - HRMS联用技术研究了副产物的性质。结果确定了副产物结构为Fe - PSMA - 11,它是由PSMA - 11分子中存在的高亲和力螯合剂HBED - CC与环境中的铁(III)结合而成。

结论

还讨论了降低低放射性标记产率风险以及提高PSMA - 11在水溶液中稳定性的策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/6243b1beaa6f/41181_2021_122_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/9aebf327a240/41181_2021_122_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/89e97cba8084/41181_2021_122_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/fea3cda88c30/41181_2021_122_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/83814dcb4d01/41181_2021_122_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/4beac2071d53/41181_2021_122_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/021278ab37d3/41181_2021_122_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/8aa8bd59a207/41181_2021_122_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/c61ca6fc5640/41181_2021_122_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/188e18b86044/41181_2021_122_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/1519da91efaa/41181_2021_122_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/6243b1beaa6f/41181_2021_122_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/9aebf327a240/41181_2021_122_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/89e97cba8084/41181_2021_122_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/fea3cda88c30/41181_2021_122_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/83814dcb4d01/41181_2021_122_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/4beac2071d53/41181_2021_122_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/021278ab37d3/41181_2021_122_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/8aa8bd59a207/41181_2021_122_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/c61ca6fc5640/41181_2021_122_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/188e18b86044/41181_2021_122_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/1519da91efaa/41181_2021_122_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/775b/7990985/6243b1beaa6f/41181_2021_122_Fig11_HTML.jpg

相似文献

1
An HPLC and UHPLC-HRMS approach to study PSMA-11 instability in aqueous solution.一种用于研究PSMA - 11在水溶液中不稳定性的高效液相色谱和超高效液相色谱 - 高分辨质谱方法。
EJNMMI Radiopharm Chem. 2021 Mar 24;6(1):14. doi: 10.1186/s41181-021-00122-3.
2
Automated radiolabelling of [Ga]Ga-PSMA-11 (gallium (Ga)-gozetotide) using the Locametz® kit and two generators.使用Locametz®试剂盒和两种发生器对[镓(Ga)]Ga-PSMA-11(镓(Ga)-戈泽托肽)进行自动化放射性标记。
EJNMMI Radiopharm Chem. 2024 Apr 17;9(1):31. doi: 10.1186/s41181-024-00260-4.
3
A Specific HPLC Method to Determine Residual HEPES in [Ga]Ga-Radiopharmaceuticals: Development and Validation.一种用于测定 [Ga]Ga 放射性药物中残留 HEPES 的特定 HPLC 方法:开发与验证。
Molecules. 2022 Jul 13;27(14):4477. doi: 10.3390/molecules27144477.
4
Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE.在生物医学回旋加速器上进行多居里镓-68的生产以及PSMA-11和DOTATATE的自动放射性标记。
EJNMMI Radiopharm Chem. 2021 Jan 7;6(1):1. doi: 10.1186/s41181-020-00114-9.
5
Validation of a [AlF]PSMA-11 preparation for clinical applications.用于临床应用的[AlF]PSMA - 11制剂的验证。
Appl Radiat Isot. 2017 Dec;130:102-108. doi: 10.1016/j.apradiso.2017.09.003. Epub 2017 Sep 6.
6
Development and Validation of a High-Pressure Liquid Chromatography Method for the Determination of Chemical Purity and Radiochemical Purity of a [Ga]-Labeled Glu-Urea-Lys(Ahx)-HBED-CC (Positron Emission Tomography) Tracer.一种用于测定[镓]标记的Glu-Urea-Lys(Ahx)-HBED-CC(正电子发射断层扫描)示踪剂化学纯度和放射化学纯度的高压液相色谱法的开发与验证
ACS Omega. 2017 Oct 31;2(10):7120-7126. doi: 10.1021/acsomega.7b00677. Epub 2017 Oct 25.
7
Ga, Sc and Lu-labeled AAZTA-PSMA-617: synthesis, radiolabeling, stability and cell binding compared to DOTA-PSMA-617 analogues.镓、钪和镥标记的AAZTA-PSMA-617:与DOTA-PSMA-617类似物相比的合成、放射性标记、稳定性及细胞结合情况
EJNMMI Radiopharm Chem. 2020 Nov 26;5(1):28. doi: 10.1186/s41181-020-00107-8.
8
Synthesis and pre-clinical evaluation of a new class of high-affinity F-labeled PSMA ligands for detection of prostate cancer by PET imaging.一类用于正电子发射断层扫描(PET)成像检测前列腺癌的新型高亲和力F标记前列腺特异性膜抗原(PSMA)配体的合成及临床前评估。
Eur J Nucl Med Mol Imaging. 2017 Apr;44(4):647-661. doi: 10.1007/s00259-016-3556-5. Epub 2016 Nov 15.
9
Optimization of Precursor Preparation in PSMA-11 Radiolabeling to Obtain a Highly Reproducible Radiochemical Yield.优化PSMA-11放射性标记中前体的制备以获得高度可重复的放射化学产率。
Pharmaceuticals (Basel). 2022 Mar 11;15(3):343. doi: 10.3390/ph15030343.
10
Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling.用于镓-68放射性标记的大环螯合剂与非环螯合剂的比较
RSC Adv. 2017 Oct 24;7(78):49586-49599. doi: 10.1039/c7ra09076e. Epub 2017 Oct 25.

引用本文的文献

1
A comparison of routine [Ga]Ga-PSMA-11 preparation using Locametz and Illuccix kits.使用Locametz和Illuccix试剂盒进行常规[镓]镓-PSMA-11制备的比较。
EJNMMI Radiopharm Chem. 2024 Dec 18;9(1):87. doi: 10.1186/s41181-024-00317-4.
2
Quality control of [Lu]Lu-PSMA preparations using HPLC: effect of sample composition and ligand on recovery.使用高效液相色谱法对[镥]镥-PSMA制剂进行质量控制:样品组成和配体对回收率的影响。
EJNMMI Radiopharm Chem. 2022 Sep 27;7(1):24. doi: 10.1186/s41181-022-00178-9.
3
Optimization of Precursor Preparation in PSMA-11 Radiolabeling to Obtain a Highly Reproducible Radiochemical Yield.

本文引用的文献

1
EANM guideline on the validation of analytical methods for radiopharmaceuticals.欧洲核医学协会放射性药物分析方法验证指南。
EJNMMI Radiopharm Chem. 2020 Feb 12;5(1):7. doi: 10.1186/s41181-019-0086-z.
2
Tuning the properties of tris(hydroxypyridinone) ligands: efficient Ga chelators for PET imaging.调整三(羟吡啶酮)配体的性质:用于正电子发射断层扫描成像的高效 Ga 螯合剂。
Dalton Trans. 2019 Mar 26;48(13):4299-4313. doi: 10.1039/c8dt04454f.
3
Development and Validation of a High-Pressure Liquid Chromatography Method for the Determination of Chemical Purity and Radiochemical Purity of a [Ga]-Labeled Glu-Urea-Lys(Ahx)-HBED-CC (Positron Emission Tomography) Tracer.
优化PSMA-11放射性标记中前体的制备以获得高度可重复的放射化学产率。
Pharmaceuticals (Basel). 2022 Mar 11;15(3):343. doi: 10.3390/ph15030343.
4
Radiolabeled PSMA Inhibitors.放射性标记的前列腺特异性膜抗原(PSMA)抑制剂
Cancers (Basel). 2021 Dec 13;13(24):6255. doi: 10.3390/cancers13246255.
5
Highlight selection of radiochemistry and radiopharmacy developments by editorial board.编辑委员会对放射化学与放射性药物发展的重点选择。
EJNMMI Radiopharm Chem. 2021 Sep 8;6(1):31. doi: 10.1186/s41181-021-00146-9.
一种用于测定[镓]标记的Glu-Urea-Lys(Ahx)-HBED-CC(正电子发射断层扫描)示踪剂化学纯度和放射化学纯度的高压液相色谱法的开发与验证
ACS Omega. 2017 Oct 31;2(10):7120-7126. doi: 10.1021/acsomega.7b00677. Epub 2017 Oct 25.
4
Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0.镓-前列腺特异性膜抗原正电子发射断层显像/计算机断层扫描:欧洲核医学协会和美国核医学与分子影像学会联合发布的前列腺癌成像程序指南:第1.0版
Eur J Nucl Med Mol Imaging. 2017 Jun;44(6):1014-1024. doi: 10.1007/s00259-017-3670-z.
5
Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68.羟基吡啶酮螯合剂:从铁清除剂到用于镓-68正电子发射断层显像的放射性药物
Int J Mol Sci. 2017 Jan 8;18(1):116. doi: 10.3390/ijms18010116.
6
Bifunctional Gallium-68 Chelators: Past, Present, and Future.双功能镓-68螯合剂:过去、现在与未来
Semin Nucl Med. 2016 Sep;46(5):373-94. doi: 10.1053/j.semnuclmed.2016.04.003.
7
Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer.[68Ga]Ga-PSMA-HBED-CC 的新型临床前和放射性药物学研究:一种用于前列腺癌成像的新型 PET 示踪剂。
Pharmaceuticals (Basel). 2014 Jun 30;7(7):779-96. doi: 10.3390/ph7070779.
8
68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging.68Ga-配合物的亲脂性和基于脲的 PSMA 抑制剂用于 PET 成像的靶向特性。
Bioconjug Chem. 2012 Apr 18;23(4):688-97. doi: 10.1021/bc200279b. Epub 2012 Mar 13.
9
The renaissance of the ⁶⁸Ge/⁶⁸Ga radionuclide generator initiates new developments in ⁶⁸Ga radiopharmaceutical chemistry.⁶⁸Ge/⁶⁸Ga 放射性核素发生器的复兴引发了 ⁶⁸Ga 放射性药物化学的新发展。
Curr Top Med Chem. 2010;10(16):1633-68. doi: 10.2174/156802610793176738.
10
Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.用于疾病正电子发射断层扫描(PET)和单光子发射计算机断层扫描(SPECT)成像的铜、镓、铟、钇和锆等配位放射性金属。
Chem Rev. 2010 May 12;110(5):2858-902. doi: 10.1021/cr900325h.